Adage Capital Partners’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3M | Hold |
7,852,000
| – | – | 0.03% | 492 |
|
|
2025
Q1 | $17.3M | Sell |
7,852,000
-648,000
| -8% | -$1.43M | 0.03% | 454 |
|
|
2024
Q4 | $13M | Sell |
8,500,000
-350,000
| -4% | -$536K | 0.02% | 544 |
|
|
2024
Q3 | $17.6M | Buy |
8,850,000
+1,250,000
| +16% | +$2.49M | 0.03% | 482 |
|
|
2024
Q2 | $26.6M | Buy |
7,600,000
+4,689,989
| +161% | +$16.4M | 0.05% | 364 |
|
|
2024
Q1 | $8.06M | Hold |
2,910,011
| – | – | 0.02% | 635 |
|
|
2023
Q4 | $4.95M | Buy |
2,910,011
+910,011
| +46% | +$1.55M | 0.01% | 686 |
|
|
2023
Q3 | $2.06M | Buy |
2,000,000
+1,000,000
| +100% | +$1.03M | ﹤0.01% | 736 |
|
|
2023
Q2 | $1.16M | Buy |
+1,000,000
| New | +$1.16M | ﹤0.01% | 762 |
|
|
2015
Q4 | – | Sell |
-114,700
| Closed | -$2.8M | – | 715 |
|
|
2015
Q3 | $2.8M | Buy |
+114,700
| New | +$2.8M | 0.01% | 658 |
|